Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference


Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced that Chris Peetz, president and chief executive officer at Mirum will present at the virtual Jefferies 2020 Healthcare Conference on June 2, 2020 at 10:00 a.m. Pacific Time/1:00 p.m. Eastern Time.

A live audio webcast and archive of the presentation will be available in the Investors & Media section of the company website at ir.mirumpharma.com.

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). For more information, visit mirumpharma.com. Follow Mirum on Twitter, Facebook and LinkedIn.


These press releases may also interest you

at 23:19
ITRI Net Zero Day 2024 Showcases Hydrogen Innovation and Green Financing Solutions
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...

at 22:33
Identity Governance & Administration Market Projected to Reach $24.42 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

at 22:03
Contract Research Organization Services Market Projected to Reach $184.21 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 20:35
Bristow Group Announces First Quarter 2024 Investor Call
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...

at 20:25
AHF Praises Colombia for Putting Lives Before Pharma Greed
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:00
SUNRATE named one of the top 100 cross-border payment companies for 2024 by FXC Intelligence
SUNRATE, an intelligent global payment and treasury management platform has been named one of the Top 100 Cross-Border Payment Companies for 2024 by FXC Intelligence, which recognises and celebrates the most important players in the cross-border...

More news about Science and technology...


News published on and distributed by: